Citicoline as specified in the Annex may be placed on the market in the Union as a novel food ingredient in food supplements with a maximum dose of 500 mg per day and in dietary foods for special medical purposes with a maximum dose of 250 mg per serving and with a maximum daily consumption level of 1Β 000 mg from these types of foods without prejudice to Directive 1999/21/EC and Directive 2002/46/EC. Citicoline shall not be used in foods intended to be consumed by children.
The designation of citicoline authorised by this Decision on the labelling of the foodstuffs containing it shall be βciticolineβ.
Information shall be given to the consumer that foods containing citicoline are not intended to be consumed by children.
This Decision is addressed to Kyowa Hakko Europe GmbH, Am Wehrhahn 50, 40211 DΓΌsseldorf, Germany.
SPECIFICATION OF CITICOLINE
ANNEXSupplementary provisions
ANNEX
SPECIFICATION OF CITICOLINE
Definition
: Citicoline is composed of cytosine, ribose, pyrophosphate and choline.
Chemical name: Choline cytidine 5β²-pyrophosphate, Cytidine 5β²-(trihydrogen diphosphate) Pβ²-[2-(trimethylammonio)ethyl]ester inner salt
Chemical formula: C 14 H 26 N 4 O 11 P 2
Molecular weight: 488,32Β g/mol
Description
: White crystalline powder.
Identification
:
CAS No
987-78-0
pH (sample solution of 1 %)
2,5-3,5
Purity
:
Assay value
Not less than 98 % of dry matter
Loss on drying (100Β Β°C for 4 hours)
Not more than 5,0 %
Ammonium
Not more than 0,05 %
Total heavy metals (as Pb)
Not more than 10 ppm
Arsenic
Not more than 2 ppm
Free phosphoric acids
Not more than 0,1 %
5β²-Cytidylic acid
Not more than 1,0 %
Microbiological criteria
:
Total plate count
Not more than 1Β 000 cfu/g
Yeast and moulds
Not more than 100 cfu/g
Escherichia coli
Absent in 1 g